A fully human inhibitory monoclonal antibody to the Wnt receptor RYK

Area of Science:

• Molecular Biology
• Neuroscience
• Immunology

Background:

• Receptor tyrosine kinases (RTKs) are crucial cell signaling proteins.
• RYK, an RTK, plays a role in cell differentiation, migration, and axon guidance via Wnt ligand binding.
• The Wnt inhibitory factor (WIF) domain of RYK is key for Wnt ligand interaction.

Purpose of the Study:

• To generate a fully human inhibitory monoclonal antibody against the RYK WIF domain.
• To characterize the antibody's ability to block Wnt binding and inhibit RYK function.
• To explore the therapeutic potential of targeting RYK signaling.

Main Methods:

• Utilized a naive human single chain fragment variable (scFv) phage display library.
• Screened scFvs for specificity to the RYK WIF domain and competition with Wnt3a binding.
• Produced a full human IgG1κ antibody from an inhibitory scFv.
• Assessed antibody function in a Wnt5a-responsive neurite outgrowth assay.

Main Results:

• Successfully generated and characterized a fully human monoclonal antibody targeting the RYK WIF domain.
• The antibody demonstrated inhibition of Wnt5a-responsive RYK function in a neurite outgrowth assay.
• Identified scFvs that compete with Wnt3a for binding to the RYK WIF domain.

Conclusions:

• A novel human inhibitory antibody against the RYK WIF domain has been developed.
• This antibody effectively modulates RYK signaling, with implications for developmental biology and homeostasis.
• The antibody holds significant therapeutic potential for pathologies involving RYK dysregulation.